Effect of the neuraminidase mutation H274Y conferring resistance to oseltamivir on the replicative capacity and virulence of old and recent human influenza A(H1N1) viruses

The Journal of Infectious Diseases
Mariana BazGuy Boivin

Abstract

The viral fitness of neuraminidase inhibitor (NAI)-resistant influenza viruses is believed to be impaired. Unexpectedly, an oseltamivir-resistant A(H1N1) variant containing the H274Y neuraminidase (NA) mutation recently disseminated worldwide, suggesting that the replication and virulence properties of this mutant virus were not compromised. In vitro replicative capacities were determined for old (A/WSN/33, A/Mississipi/3/01, A/New Caledonia/20/99, and A/Solomon Islands/03/06) and recent (A/Brisbane/59/2007-like) influenza A(H1N1) viruses either harboring or not harboring the H274Y NA mutation. Ferrets were infected with the A/Brisbane/59/2007-like wild-type (WT) isolate and its H274Y NA variant. Old A(H1N1) WT viruses grew at higher titers than did the A/Brisbane/59/2007-like viruses in vitro. The H274Y mutation was associated with reduced viral plaque areas in cells infected with A/WSN/33 and A/Mississippi/3/01, whereas the 2 A/Brisbane/59/2007-like isolates showed similar plaque sizes. In ferrets, the pyrexic response induced by the A/Brisbane/59/2007-like H274Y mutant was significantly higher than that induced by the WT isolate. Nasal wash viral titers were significantly greater for the mutant isolate on day 2 after inocula...Continue Reading

Citations

Mar 26, 2013·Antiviral Research·Mélanie SamsonGuy Boivin
Mar 4, 2011·Antioxidants & Redox Signaling·Rossella SgarbantiAnna Teresa Palamara
Aug 26, 2011·Journal of the Royal Society, Interface·Dennis L ChaoIra M Longini
Feb 22, 2012·Journal of Virology·Christopher W SeibertNicole M Bouvier
Apr 17, 2013·Virology Journal·Sarah L FordyceLars P Nielsen
Dec 24, 2010·PloS One·Andreas LeibbrandtAndreas Grassauer
Apr 2, 2011·Future Medicinal Chemistry·Johannes KirchmairMichaela Schmidtke
Sep 22, 2015·Viruses·Timothy C M LiNelson Lee
Mar 24, 2012·Current Opinion in Virology·Tatiana BaranovichElena A Govorkova
Jun 21, 2011·Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology·Christian RenaudJanet A Englund
Jan 3, 2013·Journal of Medical Virology·Ji-Rong YangMing-Tsan Liu
Jan 4, 2013·Influenza and Other Respiratory Viruses·Dennis L Chao
Jun 15, 2011·Influenza and Other Respiratory Viruses·Jessica A BelserFrederick G Hayden
Nov 11, 2010·Transplant Infectious Disease : an Official Journal of the Transplantation Society·C RenaudM J Boeckh
Apr 8, 2011·Emerging Infectious Diseases·Christian RenaudJanet A Englund
Oct 26, 2010·Journal of Theoretical Biology·Hana M DobrovolnyCatherine A A Beauchemin
Oct 17, 2014·ELife·Colin A RussellJesse D Bloom
Aug 16, 2014·The Journal of Infectious Diseases·Henju MarjukiLarisa V Gubareva

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antimicrobial Resistance (ASM)

Antimicrobial resistance poses a significant threat to the continued successful use of antimicrobial agents for the treatment of bacterial infections.

Antimicrobial Resistance

Antimicrobial resistance poses a significant threat to the continued successful use of antimicrobial agents for the treatment of bacterial infections.

Antivirals

Antivirals are medications that are used specifically for treating viral infections. Discover the latest research on antivirals here.

Antivirals (ASM)

Antivirals are medications that are used specifically for treating viral infections. Discover the latest research on antivirals here.